(Q72145444)
Statements
Design of orally bioavailable, symmetry-based inhibitors of HIV protease (English)
D J Kempf
K C Marsh
L C Fino
P Bryant
A Craig-Kennard
H L Sham
C Zhao
S Vasavanonda
W E Kohlbrenner
N E Wideburg
1 September 1994